419 related articles for article (PubMed ID: 21069266)
1. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
2. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
Liu Y; Rubin B; Bodine PV; Billiard J
J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
[TBL] [Abstract][Full Text] [Related]
4. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
Mikels AJ; Nusse R
PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827
[TBL] [Abstract][Full Text] [Related]
5. Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases.
Minami Y; Oishi I; Endo M; Nishita M
Dev Dyn; 2010 Jan; 239(1):1-15. PubMed ID: 19530173
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q
Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497
[TBL] [Abstract][Full Text] [Related]
7. Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling.
Mikels A; Minami Y; Nusse R
J Biol Chem; 2009 Oct; 284(44):30167-76. PubMed ID: 19720827
[TBL] [Abstract][Full Text] [Related]
8. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
9. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
[TBL] [Abstract][Full Text] [Related]
10. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.
Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y
Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005
[TBL] [Abstract][Full Text] [Related]
11. Stable genetic alterations of β-catenin and ROR2 regulate the Wnt pathway, affect the fate of MSCs.
Cai SX; Liu AR; He HL; Chen QH; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
J Cell Physiol; 2014 Jun; 229(6):791-800. PubMed ID: 24590964
[TBL] [Abstract][Full Text] [Related]
12. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of Wnt signaling pathway in keloid pathogenesis.
Igota S; Tosa M; Murakami M; Egawa S; Shimizu H; Hyakusoku H; Ghazizadeh M
Int J Med Sci; 2013; 10(4):344-54. PubMed ID: 23471552
[TBL] [Abstract][Full Text] [Related]
14. Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.
O'Connell MP; Weeraratna AT
Pigment Cell Melanoma Res; 2009 Dec; 22(6):724-39. PubMed ID: 19708915
[TBL] [Abstract][Full Text] [Related]
15. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a regulates distinct signalling pathways by binding to Frizzled2.
Sato A; Yamamoto H; Sakane H; Koyama H; Kikuchi A
EMBO J; 2010 Jan; 29(1):41-54. PubMed ID: 19910923
[TBL] [Abstract][Full Text] [Related]
17. The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification.
Xin H; Xin F; Zhou S; Guan S
Int J Mol Med; 2013 Mar; 31(3):583-8. PubMed ID: 23337931
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
19. IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent.
Fukuyo S; Yamaoka K; Sonomoto K; Oshita K; Okada Y; Saito K; Yoshida Y; Kanazawa T; Minami Y; Tanaka Y
Rheumatology (Oxford); 2014 Jul; 53(7):1282-90. PubMed ID: 24599911
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts.
Liu G; Bafico A; Aaronson SA
Mol Cell Biol; 2005 May; 25(9):3475-82. PubMed ID: 15831454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
